XML 14 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Earnings - USD ($)
shares in Thousands, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues:        
Net earned premiums, principally supplemental health insurance $ 3,651 $ 4,372 $ 11,679 $ 13,406
Net investment income 920 991 2,760 2,908
Net investment gains (losses) 199 (171) 885 224
Other income (loss) 50 45 168 132
Total revenues 4,820 5,237 15,492 16,670
Benefits and expenses:        
Benefits and claims, net 2,340 2,609 7,125 7,996
Acquisition and operating expenses:        
Amortization of deferred policy acquisition costs 268 278 858 869
Insurance commissions 267 311 846 952
Insurance and other expenses [1] 783 869 2,412 2,582
Interest expense 59 57 171 181
Total acquisition and operating expenses 1,377 1,515 4,287 4,584
Total benefits and expenses 3,717 4,124 11,412 12,580
Earnings before income taxes 1,103 1,113 4,080 4,090
Income taxes (493) 225 64 804
Net earnings $ 1,596 $ 888 $ 4,016 $ 3,286
Net earnings per share:        
Basic (in dollars per share) $ 2.54 $ 1.33 $ 6.28 $ 4.84
Diluted (in dollars per share) $ 2.53 $ 1.32 $ 6.25 $ 4.82
Weighted-average outstanding common shares used in computing earnings per share (In thousands):        
Basic (in shares) 629,350 668,762 639,862 678,509
Diluted (in shares) 631,946 671,925 642,597 681,521
Cash dividends per share $ 0.40 $ 0.33 $ 1.20 $ 0.99
[1] Includes expense of $48 in the nine-month period ended September 30, 2021 for the early extinguishment of debt.